Individual Stress Vulnerability Is Predicted by Short-Term Memory and AMPA Receptor Subunit Ratio in the Hippocampus
暂无分享,去创建一个
Mathias V. Schmidt | F. Holsboer | J. Deussing | W. Wurst | D. Trümbach | E. Binder | N. Datson | M. Müller | M. Uhr | P. Weber | S. Scharf | Christian Namendorf | K. Wagner | C. Liebl | C. Kühne | Tamara Gerlach | M. Schmidt
[1] B. Giros,et al. Antidepressant-like effects of an AMPA receptor potentiator under a chronic mild stress paradigm. , 2010, The international journal of neuropsychopharmacology.
[2] F. Holsboer,et al. High susceptibility to chronic social stress is associated with a depression-like phenotype , 2010, Psychoneuroendocrinology.
[3] P. Cowen,et al. A Functional Magnetic Resonance Imaging Study of Verbal Working Memory in Young People at Increased Familial Risk of Depression , 2010, Biological Psychiatry.
[4] Hong-wei Dong,et al. Are the Dorsal and Ventral Hippocampus Functionally Distinct Structures? , 2010, Neuron.
[5] K. Hashimoto. Emerging role of glutamate in the pathophysiology of major depressive disorder , 2009, Brain Research Reviews.
[6] M. Banasr,et al. Chronic treatment with AMPA receptor potentiator Org 26576 increases neuronal cell proliferation and survival in adult rodent hippocampus , 2009, Psychopharmacology.
[7] N. Hasebe,et al. Effects of antidepressants on GluR2 Q/R site-RNA editing in modified HeLa cell line , 2009, Neuroscience Research.
[8] Mark A Good,et al. Enhanced long-term and impaired short-term spatial memory in GluA1 AMPA receptor subunit knockout mice: evidence for a dual-process memory model. , 2009, Learning & memory.
[9] H. Manji,et al. The Role of the Tripartite Glutamatergic Synapse in the Pathophysiology and Therapeutics of Mood Disorders , 2009, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.
[10] Marian Joëls,et al. Version unknown SOURCE ( OR PART OF THE FOLLOWING SOURCE ) : Type article Title Corticosterone alters AMPAR mobility and facilitates bidirectional synaptic plasticity , 2009 .
[11] S. Southwick,et al. Social support and resilience to stress across the life span: A neurobiologic framework , 2008, Current psychiatry reports.
[12] R. Sprengel,et al. AMPA receptor subunit 1 (GluR‐A) knockout mice model the glutamate hypothesis of depression , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[13] Carlos A. Zarate,et al. Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders , 2008, Nature Reviews Drug Discovery.
[14] R. McIntyre,et al. What Are the Implications of the STAR*D Trial for Primary Care? A Review and Synthesis. , 2008, Primary care companion to the Journal of clinical psychiatry.
[15] Guang Chen,et al. Cellular Mechanisms Underlying the Antidepressant Effects of Ketamine: Role of α-Amino-3-Hydroxy-5-Methylisoxazole-4-Propionic Acid Receptors , 2008, Biological Psychiatry.
[16] C. Zarate,et al. The role of glutamate in mood disorders: Results from the ketamine in major depression study and the presumed cellular mechanism underlying its antidepressant effects , 2007, Current psychiatry reports.
[17] T. Macedo,et al. Methamphetamine induces alterations on hippocampal NMDA and AMPA receptor subunit levels and impairs spatial working memory , 2007, Neuroscience.
[18] P. Greengard,et al. Involvement of AMPA receptor phosphorylation in antidepressant actions with special reference to tianeptine , 2007, The European journal of neuroscience.
[19] Chris J. McBain,et al. The Role of the GluR2 Subunit in AMPA Receptor Function and Synaptic Plasticity , 2007, Neuron.
[20] F. Holsboer,et al. Persistent neuroendocrine and behavioral effects of a novel, etiologically relevant mouse paradigm for chronic social stress during adolescence , 2007, Psychoneuroendocrinology.
[21] Steven Finkbeiner,et al. NMDA and AMPA receptors: old channels, new tricks , 2007, Trends in Neurosciences.
[22] A. Arai,et al. Pharmacology of ampakine modulators: from AMPA receptors to synapses and behavior. , 2007, Current drug targets.
[23] M. O'Neill,et al. AMPA receptor potentiators: application for depression and Parkinson's disease. , 2007, Current drug targets.
[24] J. Witkin,et al. AMPA receptors in the therapeutic management of depression. , 2007, CNS & neurological disorders drug targets.
[25] Takeshi Yamada,et al. Short communication Correlation between plasma levels of glutamate, alanine and serine with severity of depression , 2006 .
[26] Paul J Carlson,et al. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. , 2006, Archives of general psychiatry.
[27] E. Chudin,et al. A Model of Technical Variation of Microarray Signals , 2006, J. Comput. Biol..
[28] E. Nisenbaum,et al. LY404187: a novel positive allosteric modulator of AMPA receptors. , 2006, CNS drug reviews.
[29] E. Nisenbaum,et al. A role for AMPA receptors in mood disorders. , 2006, Biochemical pharmacology.
[30] M. Popoli,et al. Regulation of Editing and Expression of Glutamate α-Amino-Propionic-Acid (AMPA)/Kainate Receptors by Antidepressant Drugs , 2006, Biological Psychiatry.
[31] S. Brady,et al. Gender differences in response of hippocampus to chronic glucocorticoid stress: Role of glutamate receptors , 2006, Journal of neuroscience research.
[32] R. W. Draft,et al. Restoration of spatial working memory by genetic rescue of GluR-A–deficient mice , 2005, Nature Neuroscience.
[33] N. Datson,et al. Expression profiling in laser‐microdissected hippocampal subregions in rat brain reveals large subregion‐specific differences in expression , 2004, The European journal of neuroscience.
[34] JianLi Wang. Work stress as a risk factor for major depressive episode(s) , 2004, Psychological Medicine.
[35] H. Manji,et al. Modulation of Synaptic Plasticity by Antimanic Agents: The Role of AMPA Glutamate Receptor Subunit 1 Synaptic Expression , 2004, The Journal of Neuroscience.
[36] H. Anisman,et al. Validation of a simple, ethologically relevant paradigm for assessing anxiety in mice , 2003, Biological Psychiatry.
[37] Olga V. Demler,et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). , 2003, JAMA.
[38] M. Bergeron,et al. Chronic AMPA receptor potentiator (LY451646) treatment increases cell proliferation in adult rat hippocampus , 2003, Neuropharmacology.
[39] David Bleakman,et al. An AMPA receptor potentiator modulates hippocampal expression of BDNF: an in vivo study , 2002, Neuropharmacology.
[40] I. Izquierdo,et al. Molecular Pharmacological Dissection of Short- and Long-Term Memory , 2002, Cellular and Molecular Neurobiology.
[41] P. Skolnick,et al. Intra- and interstrain differences in models of “behavioral despair” , 2001, Pharmacology Biochemistry and Behavior.
[42] J. Meador-Woodruff,et al. Striatal ionotropic glutamate receptor expression in schizophrenia, bipolar disorder, and major depressive disorder , 2001, Brain Research Bulletin.
[43] D. Bleakman,et al. Pharmacological effects of AMPA receptor potentiators LY392098 and LY404187 on rat neuronal AMPA receptors in vitro , 2001, Neuropharmacology.
[44] P. Skolnick,et al. Antidepressant-like actions of an AMPA receptor potentiator (LY392098) , 2001, Neuropharmacology.
[45] P. Ornstein,et al. Novel AMPA receptor potentiators LY392098 and LY404187: effects on recombinant human AMPA receptors in vitro , 2001, Neuropharmacology.
[46] D. Lodge,et al. Potentiation of responses to AMPA on central neurones by LY392098 and LY404187 in vivo , 2001, Neuropharmacology.
[47] M. Oitzl,et al. A refined method for sequential blood sampling by tail incision in rats , 2000, Laboratory animals.
[48] D. Charney. Monoamine dysfunction and the pathophysiology and treatment of depression. , 1998, The Journal of clinical psychiatry.
[49] Michael C. Neale,et al. Stressful life events, genetic liability, and onset of an episode of major depression in women. , 1995, The American journal of psychiatry.
[50] J. Kleinman,et al. Properties of [3H]AMPA Binding in Postmortem Human Brain from Psychotic Subjects and Controls: Increases in Caudate Nucleus Associated with Suicide , 1993, Experimental Neurology.
[51] D. Choquet,et al. [Surface mobility of postsynaptic AMPARs tunes synaptic transmission]. , 2008, Medecine sciences : M/S.
[52] H. Kornhuber,et al. Increased serum glutamate in depressed patients , 2004, Archiv für Psychiatrie und Nervenkrankheiten.